SEMPRA - EQUITY AND EARNINGS PER COMMON SHARE (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Schedule of Other Ownership Interests

The following table summarizes net income attributable to Sempra and transfers (to) from NCI, which shows the effects of changes in Sempra’s ownership interest in its subsidiaries on Sempra’s shareholders’ equity.

NET INCOME ATTRIBUTABLE TO SEMPRA AND TRANSFERS (TO) FROM NCI
(Dollars in millions)
	Three months ended March 31, 2023
Sempra:
Net income attributable to Sempra	$	980
Transfers (to) from NCI:
Increase in shareholders’ equity for sale of NCI	18
Net transfers (to) from NCI	18
Change from net income attributable to Sempra and transfers (to) from NCI	$	998

Schedule of Earnings Per Share, Basic and Diluted

EARNINGS PER COMMON SHARE COMPUTATIONS
(Dollars in millions, except per share amounts; shares in thousands)
	Three months ended March 31,
	2024		2023
Sempra:
Numerator:
Earnings attributable to common shares	$	801	$	969
Denominator:
Weighted-average common shares outstanding for basic EPS(1)	632,821		629,838
Dilutive effect of common shares sold forward	673		—
Dilutive effect of stock options and RSUs(2)	1,860		2,410
Weighted-average common shares outstanding for diluted EPS	635,354		632,248
EPS:
Basic	$	1.27	$	1.54
Diluted	$	1.26	$	1.53

(1)    Includes 624 and 721 fully vested RSUs held in our Deferred Compensation Plan for the three months ended March 31, 2024 and 2023, respectively. These fully vested RSUs are included in weighted-average common shares outstanding for basic EPS because there are no conditions under which the corresponding shares will not be issued.

(2)    Due to market fluctuations of both Sempra common stock and the comparative indices used to determine the vesting percentage of our total shareholder return performance-based RSUs, which we discuss in Note 10 of the Notes to Consolidated Financial Statements in the Annual Report, dilutive RSUs may vary widely from period-to-period.